Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Late-Stage Pipeline

29%

4 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

9 recruiting

Enrollment Performance

Analytics

Phase 4
4(57.1%)
N/A
3(42.9%)
7Total
Phase 4(4)
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT07421895Recruiting

A Prospective Multicenter Observational Real-world Study of Retained Products of Conception

Role: collaborator

NCT07290699Phase 4Not Yet Recruiting

Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT07114120Phase 4Recruiting

Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules

Role: collaborator

NCT05198154Recruiting

ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

Role: collaborator

NCT06713421Not ApplicableRecruiting

Effect of Premedication With Pronase on Mucosal Cleanliness During EGD

Role: collaborator

NCT06790108Not ApplicableRecruiting

Validation of an AI-Assisted Mediastinal EUS System for Training Improvement: a Prospective, Multi-Center, Randomized Trial

Role: collaborator

NCT06790134Not ApplicableRecruiting

Validation of an AI-Assisted Pancreatic EUS System for Training Improvement: a Prospective, Multi-Center, Randomized Trial

Role: collaborator

NCT05598528Recruiting

Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)

Role: collaborator

NCT04707261Phase 4Recruiting

Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)

Role: collaborator

NCT06162780Recruiting

TEER for Severe DMR of Low to Intermediate Surgery Risk

Role: collaborator

NCT04937192Unknown

SNP-based Prediction of Recurrence Risk in Kidney Stone Patients

Role: collaborator

NCT04678934Unknown

Cerebral Lesion and Neurocognitive Status Changes After TAVR

Role: collaborator

NCT04045171Unknown

Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome

Role: collaborator

All 14 trials loaded